Chem. J. Chinese Universities

• 研究论文 • Previous Articles     Next Articles

Chemiluminescent Enzyme Immunoassay for Cardiac Troponin I Detection——Optimization of Experimental Parameters

HE Nong-Yue1, GUO Hui-Shi1, GU Chun-Rong2, YANG Di2, ZHANG JI-Nan2   

    1. State Key Laboratory of Bioelectronics, Southeast University, Nanjing 210096, China;
    2. Institute of Cardiovascular Disease, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
  • Received:2006-06-14 Revised:1900-01-01 Online:2007-02-10 Published:2007-02-10
  • Contact: HE Nong-Yue

Abstract: Chemiluminescent immunoassays(CLIA) were intensively studied in antigen/antibody detection, due to the extremely sensitive chemiluminescent detection techniques. Here we present a sensitive immuno-assay for cTnI based on this concept. The assay was executed as the traditional ELISA except that two major modifications were made to obtain a rapid test and a high sensitivity. The first modification is that the two-step dual monoclonal antibody “sandwich” principle of traditional ELISA was substituted by a one-step immuno-reaction mode which decreased the turnaround time greatly. The second modification is that a chemiluminescent substrate(AMPPD) and chemiluminescent detection techniques, which elevated the sensitivity remar-kably, were used to replace the colorimetric substrate and colorimetric detection method in ELISA. The detection procedure of the assay could be fulfilled within 75 min. A linear range between the luminescent signal current and the concentration of cTnI from 0.04 to 36.2 ng/mL and a detection limit of 0.02 ng/mL were obtained. The established method was tested by determining cTnI in real samples by using ELISA for comparison analysis, and good results were obtained.

Key words: Chemiluminescent immunoassay, Acute myocardial infarction, AMPPD, Cardiac troponin I(cTnI)

CLC Number: 

TrendMD: